USP Navigation, Compounding Updates, and the Use of Hormone Therapy

D’Youville School of Pharmacy Continuing Pharmacy Education Program , in collaboration with the Pharmacist’s Association of Western New York

Please Note: This is a Live Offering 
Presents:

USP Navigation, Compounding Updates, and the Use of Hormone Therapy

with Matthew Lester, RPh, MBA

and

Sara Hover, RPh, FAARM

Target Audience: Pharmacists in all practice setttings

Type of Activity: This is a knowledge-based activity

Fees:  PAWNY Members: $25

Students/Residents/Pharmacy Technicians: $10

Non-members: $50

Learning Objectives

Matthew Lester :

1. Review changes in state and federal oversight of compounding pharmacies, including USP 795, 797, and 800.

2. Review recent USP regulatory updates, considerations from FDA guidance documents, and strategies for ensuring safety and quality with each compounded medication. Walk away with a better understanding of the changes impacting your pharmacy's compounding practice so you can ensure compliance with changes on the horizon.

3. Summarize FDA guidance documents about insanitary conditions at compounding facilities.

4. Outline safety and quality considerations and strategies for reducing common compounding errors.

Sara Hover :

1. Understand the fundamentals of female hormones, including estradiol and progesterone and their roles beyond reproduction.
2. Explore the complex relationship between female hormones and brain function, highlighting the impact on cognitive processes such as memory, attention, and decision-making.
3. Examine the influence of female hormones on emotional well-being, mood regulation, and mental health, including the potential implications for conditions such as premenstrual syndrome (PMS), postpartum depression and menopause-related mood disorders.
4. Discuss recent research findings on the effects of hormone therapy, hormonal contraceptives and natural hormonal fluctuations on brain health and cognitive performance.
5. Recognize the broader implications of understanding the impact of female hormones on the brain, including the development of personalized healthcare approaches and potential interventions for women’s mental well-being.

Financial Support Acknowledgement: No financial support to disclose
For questions, contact Rachel Gorodetsky:  gorodetr@dyc.edu

Continuing Education Information: D’Youville School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This knowledge-based activity has been assigned ACPE #: 0645-9999-22-003-H06-P and will award 2 contact hours (0.2 CEU) of continuing pharmacy education credit. Credit will be uploaded to CPE Monitor to attendees who complete the CE post-test and evaluation form.